Association between pulse wave velocity and a marker of renal tubular damage (N-Acetyl-β-D-Glucosaminidase) in patients without diabetes

Journal of Clinical Hypertension

Volumn 17, Issue 4, 2015, Pages 290-297

  Ouchi, Motoshi ^a   Oba, Kenzo ^b   Saigusa, Taro ^c   Watanabe, Kentaro ^d   Ohara, Makoto ^e   Matsumura, Noriaki ^c   Suzuki, Tatsuya ^c   Anzai, Naohiko ^a   Tsuruoka, Shuichi ^f   Yasutake, Masahiro ^c,f  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Department of Internal Medicine Oarai Coast Core Clinic   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIPPON MEDICAL SCHOOL GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; N ACETYL BETA GLUCOSAMINIDASE; ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKER;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; COMPLICATION; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; URINE; VERY ELDERLY;

ACETYLGLUCOSAMINIDASE; ADULT; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; BIOMARKERS; BLOOD FLOW VELOCITY; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; VASCULAR STIFFNESS;

EID: 84926200704     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12492     Document Type: Article

References (50)

1. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657-663.
2. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
3. Tanaka H, Munakata M, Kawano Y, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens. 2009;27:2022-2027.
4. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25:359-364.
5. Hung CS, Lin JW, Hsu CN, et al. Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks. Nutr Metab Cardiovasc Dis. 2009;19:241-246.
6. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
7. Fried LF, Shlipak MG, Crump C, et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol. 2003;41:1364-1372.
8. Damman K, Masson S, Hillege HL, et al. Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J. 2011;32:2705-2712.
9. Damman K, Voors AA, Hillege HL, et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail. 2010;12:974-982.
10. Le Hir M, Dubach UC, Schmidt U. Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry. 1979;63:245-251.
11. Weitgasser R, Schnoell F, Gappmayer B, Kartnig I. Prospective evaluation of urinary N-acetyl-β-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care. 1999;22:1882-1886.
12. Taal MW. Arterial stiffness in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2014;23:169-173.
13. Chen SC, Chang JM, Liu WC, et al. Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:724-732.
14. Liu CS, Pi-Sunyer FX, Li CI, et al. Albuminuria is strongly associated with arterial stiffness, especially in diabetic or hypertensive subjects-a population-based study (Taichung Community Health Study, TCHS). Atherosclerosis. 2010;211:315-321.
15. Ishikawa T, Hashimoto J, Morito RH, et al. Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama study. Am J Hypertens. 2008;21:413-418.
16. Kohara K, Tabara Y, Tachibana R, et al. Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res. 2004;27:471-477.
17. Yuzawa Y, Ito I. Urinary NAG, β2 microglobulin - renal tubular injury, AKI (acute kidney injury) and biomarker. Nippon Naika Gakkai Zasshi. 2008;97:971-978 [Article in Japanese].
18. L-Type NAG [Package Insert]. Osaka, Japan: Wako Pure Chemical Industries, Ltd.; 2013.
19. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-992.
20. Kashiwagi A, Kasuga M, Araki E, et al; Committee on the Standardization of Diabetes Mellitus Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig. 2012;3:39-40.
21. Helmersson-Karlqvist J, Larsson A, Carlsson AC, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. Atherosclerosis. 2013;227:408-413.
22. Yoon HE, Shin DI, Kim SJ, et al. Brachial-ankle pulse wave velocity predicts decline in renal function and cardiovascular events in early stages of chronic kidney disease. Int J Med Sci. 2013;10:1430-1436.
23. Kawamoto R, Kohara K, Tabara Y, et al. An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med. 2008;47:593-598.
24. Liu IT, Wu JS, Yang YC, et al. Mild chronic kidney disease associated with greater risk of arterial stiffness in elderly adults. J Am Geriatr Soc. 2013;61:1758-1762.
25. Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:353-365.
26. Metcalfe W. How does early chronic kidney disease progress? A background paper prepared for the UK Consensus Conference on early chronic kidney disease. Nephrol Dial Transplant. 2007;22(suppl 9):ix26-ix30.
27. Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol. 2006;17:2964-2966.
28. Hong JD, Lim IS. Correlation between glomerular filtration rate and urinary N-acetyl-β-D-glucosaminidase in children with persistent proteinuria in chronic glomerular disease. Korean J Pediatr. 2012;55:136-142.
29. John M, Hussain S, Prayle A, et al. Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD. Respir Res. 2013;14:31.
30. Saijo Y, Utsugi M, Yoshioka E, et al. Association of β2-microglobulin to arterial stiffness in Japanese subjects. Hypertens Res. 2005;28:505-511.
31. Jovanović D, Krstivojević P, Obradović I, et al. Serum cystatin C and β2-microglobulin as markers of glomerular filtration rate. Ren Fail. 2003;25:123-133.
32. Ellis BG, Tucker SM, Thompson AE, Price RG. Presence of serum and tissue forms of N-acetyl-β-glucosaminidase in urine from patients with renal disease. Clin Chim Acta. 1975;64:195-202.
33. Capodicasa E, Angelini A, Tassi C. Isoenzyme A and urinary N-acetyl-β-D-glucosaminidase activity in normal pregnancy. Ren Fail. 2011;33:650-653.
34. Paigen K, Peterson J. Coordinacy of lysosomal enzyme excretion in human urine. J Clin Invest. 1978;61:751-762.
35. Gibey R, Dupond JL, Peltier H, et al. An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG). Pathol Biol (Paris). 1986;34:342-345 [Article in French].
36. Morita A, Numata Y, Kosugi Y, et al. Stabilities of N-acetyl-β-D-glucosaminidase (NAG) isoenzymes in urine: advantage of NAG isoenzyme B measurement in clinical applications. Clin Chim Acta. 1998;278:35-43.
37. Ouchi M, Oba K, Motoyama M, et al. Postprandial glycemic control conditions in relation to urinary N-Acetyl-β-D-glucosaminidase in patients with type 2 diabetes mellitus without low glomerular filtration rate. Diabetes Technol Ther. 2014;16:41-47.
38. Ouchi M, Oba K, Ohara M, et al. Change in urinary N-acetyl-β-D-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus. Clin Chim Acta. 2014;433:88-92.
39. Ouchi M, Suzuki T, Hashimoto M, et al. Urinary N-acetyl-β-D-glucosaminidase levels are positively correlated with 2-hr plasma glucose levels during oral glucose tolerance testing in prediabetes. J Clin Lab Anal. 2012;26:473-480.
40. Tomiyama H, Hashimoto H, Matsumoto C, et al. Effects of aging and persistent prehypertension on arterial stiffening. Atherosclerosis. 2011;217:130-134.
41. Lee YJ, Lee JW, Kim JK, et al. Elevated white blood cell count is associated with arterial stiffness. Nutr Metab Cardiovasc Dis. 2009;19:3-7.
42. Yambe M, Tomiyama H, Yamada J, et al. Arterial stiffness and progression to hypertension in Japanese male subjects with high normal blood pressure. J Hypertens. 2007;25:87-93.
43. Tomiyama H, Arai T, Koji Y, et al. The age-related increase in arterial stiffness is augmented in phases according to the severity of hypertension. Hypertens Res. 2004;27:465-470.
44. Lantelme P, Mestre C, Lievre M, et al. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension. 2002;39:1083-1087.
45. Tomiyama H, Koji Y, Yambe M, et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension. 2005;45:997-1003.
46. Yamanouchi T, Minoda S, Ogata N, et al. Prolonged hyperalimentation as a possible cause of renal tubular dysfunction: evaluation of 1, 5-anhydro-D-glucitol resorption and N-acetylglucosaminidase excretion in humans. Clin Sci (Lond). 1995;88:203-210.
47. Inoue T, Matsunaga R, Morooka S, Uehara Y. Serum N-acetyl-beta-D-gulucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease. Atherosclerosis. 2000;149:117-122.
48. Yoshikawa R, Wada J, Seiki K, et al. Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients. Diabetes Res Clin Pract. 2007;76:358-367.
49. Oba K, Hirai M, Ajiro Y, et al. Effect of age on urinary excretion of N-acetyl-β-D-glucosaminidase. J Nippon Med Sch. 1999;66:33-36.
50. Yamanouchi T, Kawasaki T, Yoshimura T, et al. Association between serum 1, 5-anhydroglucitol and urinary excretion of N-Acetyl-β-D-glucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up. Diabetes Care. 1998;21:619-624.